ChartRow logo
Data provided bySource: Twelve Data
TAK
$21.43+1.47%
as of close, Nov 13, 2026
☾ AH $21.43 +1.47%
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)Stock · HealthcareJapanese Stock Market · 1.1% of EWJMSCI EAFE · 0.2% of EFAMSCI World · 0.06% of URTHMSCI ACWI · 0.05% of ACWI
PeersHLNTEVAZTSGSKSNYVTRS
Share this page

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trailing returns

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s 10-year return is +3.1% a year (CAGR) (+35.1% cumulative). How Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) has performed over the last day, week, month and year, over 5 and 10 years, and since inception, through November 13, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

Data provided bySource: Twelve Data

To 2026-11-13. Price return + dividends = total return. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
Cumulative
1 day+1.5%+0.0%+1.5%—
5 days+2.0%+0.0%+2.0%-1.2%Nov 11
1 month+15.7%+0.0%+15.7%-2.1%Oct 29
YTD+37.5%+0.0%+37.5%-20.1%Jun 3
Per year (CAGR)
1 year+50.5%+0.0%+50.5% CAGR-20.1%Jun 2026
5 years+8.2%+2.5%+10.7% CAGR+66.6% total-26.4%Jun 2024
10 years-0.2%+3.2%+3.1% CAGR+35.1% total-59.6%Oct 2022
Since 2010+0.0%+3.5%+3.5% CAGR+77.8% total-59.6%Oct 2022

Growth of TAK#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+10.7%/year · +66.6%
  • 10 years+3.1%/year · +35.1%
  • Since inception (2010)+3.5%/year · +77.8%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-11-13). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in TAK's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s 10-year return?
Over the last 10 years, Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) returned about +3.1% a year annualized (+35.1% cumulative total return).
What is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)'s return since inception?
Since 2010, Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) has compounded at about +3.5% a year — +77.8% in total.

More on Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)